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1Reduced delivery of glucose and oxygen during brain isch-emia can cause energy failure (ATP depletion), which 
can in turn trigger processes leading to cell death. Glucose 
can support glycolytic ATP production even in the absence of 
oxygen, and it would seem to follow that increased glucose 
in the residual blood flow to ischemic brain should increase 
cell survival. This was tested experimentally in a rat model of 
ischemia/reperfusion by Pulsinelli et al1 several decades ago. 
Glucose had a striking effect, but in the direction opposite 
to what might be expected: rats in which circulating blood 
glucose was increased by intravenous infusion had far more 
extensive brain injury and mortality compared with normo-
glycemic rats. This experiment has subsequently been revis-
ited dozens of times, using different animal species, stroke 
models, glucose concentrations, timing of glucose elevations, 
and permutations of these factors. The net result is one of the 
most robust in all of stroke research: hyperglycemia almost 
always exacerbates brain injury.2,3 Clinical experience mirrors 
the animal literature in these respects, because both retro-
spective studies and patient registries show a striking correla-
tion between elevated admission glucose concentrations and 
poor outcomes.4 Hyperglycemia is similarly associated with 
increased hemorrhage formation and poor outcome in patients 
treated with tissue plasminogen activator.5–7
Random blood glucose levels are ≈4.4 to 6.1 mmol/L in 
both humans and rodents, with rodents being the species 
most commonly used for experimental stroke. The definition 
of hyperglycemia varies somewhat in stroke studies, ranging 
from 6.1 to >10 mmol/L glucose. Using these definitions, 
hyperglycemia is found at presentation in 30% to 60% of all 
patients with stroke.8,9 Some of these patients are diabetic, but 
acute, poststroke hyperglycemia is a sympathomimetic stress 
response in most.
Despite the frequency of hyperglycemia in stroke and >30 
years of congruent experimental and clinical observations 
linking hyperglycemia to poor outcomes, it remains uncertain 
whether hyperglycemia should be corrected in patients with 
acute stroke. This uncertainty stems, in part, from a concern 
that hyperglycemic stress response is to some extent adaptive, 
and that some regions of ischemic brain may require increased 
glucose delivery to survive ischemia. A related concern stems 
from the practical difficulty in preventing an overcorrection 
of hyperglycemia in acutely ill patients, and providers are 
understandably reticent to lower blood glucose when an over-
shoot could be catastrophic. Against this background, we aim 
to summarize what is now known about the mechanisms by 
which hyperglycemia can exacerbate ischemic brain injury in 
the acute stroke setting. These mechanisms are then placed in 
the context of relevant clinical observations and clinical trials 
that address this complex issue.
Dual Roles of Glucose in Energy Metabolism 
and Oxidative Stress
The central nervous system is unique in that it requires a con-
tinuous supply of glucose for normal function. All other tis-
sues, including the heart, can readily metabolize fatty acids, 
amino acids, and ketone bodies in place of glucose substrate, 
but the blood–brain barrier prevents rapid influx of these alter-
native substrates under most conditions.10 Glucose is metabo-
lized almost completely to CO2 in normal brain. There can be 
transient local metabolism of glucose to lactate in response 
to local brain activity, but the lactate so produced is subse-
quently metabolized oxidatively, or else escapes into the 
venous system.11 Blood glucose concentrations are normally 
4 to 6 mmol/L, essentially all of which can be extracted by the 
brain. Normal, fully oxygenated blood carries ≈9 mmol/L O2, 
of which only a portion can be extracted.10 Because 6 moles of 
O2 are required to oxidize each mole of glucose, this leaves a 
large molar excess of glucose available for anaerobic metabo-
lism to lactate when blood delivery of oxygen falls short of 
demand (Figure 1). Anaerobic glucose metabolism can rap-
idly generate ATP, as it occurs normally in exercising muscle. 
However, this process also produces lactic acid, and under 
ischemic conditions, lactic acid accumulates and reduces 
tissue pH (Figures 1 and 2). This effect is magnified during 
hyperglycemia.
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Independent of its role in energy metabolism, glucose is 
also required for both quenching and production of reactive 
oxygen species in the central nervous system. This stems from 
the fact that glucose is the exclusive substrate for nicotinamide 
adenine dinucleotide phosphate (NADPH) production through 
the hexose monophosphate shunt (Figure 1). NADPH pro-
duced by this pathway is used by the enzyme glutathione 
reductase to convert oxidized glutathione (glutathione disul-
fide) back to reduced glutathione, the major thiol antioxidant 
in brain. Glutathione production is impaired during hypogly-
cemia,12 and this may limit the capacity of the brain to counter 
oxidative stress. It is unknown whether glutathione production 
can be accelerated by hyperglycemia.
Somewhat paradoxically, NADPH is also used by cells 
to generate reactive oxygen species: NADPH used by nitric 
oxide synthase to generate nitric oxide (NO˙) and by NADPH 
oxidase to generate superoxide (O2˙; Figure 1). These reac-
tive oxygen species are important mediators of ischemic brain 
injury. Glucose supply to the hexose monophosphate shunt 
can be rate-limiting for O2˙ production, and O2˙ production 
in the brain can be accelerated by hyperglycemia.13 O2˙ can 
also be generated from the electron transport chain of dam-
aged mitochondria during ischemia/reperfusion14; however, 
this process is also ultimately glucose-dependent because glu-
cose is the source for almost all reducing equivalents passing 
through the mitochondrial electron transport chain in central 
nervous system tissues (Figure 1).
Effects of Blood Glucose Concentrations on 
Ischemic Brain Injury
These multiple roles for glucose in the brain lead to multiple 
and sometimes opposing effects of glucose on ischemic brain 
injury (Figure 1). On one hand, low blood glucose concen-
trations (hypoglycemia) may exacerbate ischemic injury by 
reducing glucose delivery and hastening energy failure, partic-
ularly when oxygen supply is compromised or mitochondria 
are damaged. Hypoglycemia does not ordinarily cause neu-
ronal death unless blood levels fall very low, <1 mmol/L, but 
given the increased reliance on ischemic tissue for anaerobic 
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Figure 1. Metabolic fates of glucose relevant to ischemic injury. Products thought to have favorable effects on stroke outcome are shown 
in blue, and products thought to have deleterious effects are in red. Glucose metabolized by hexose monophosphate provides reducing 
equivalents for producing nicotinamide adenine dinucleotide phosphate (NADPH). NADPH in turn can be used by glutathione reduc-
tase (GR) to regenerate glutathione (GSH) from glutathione disulfide (GSSG) and for the production of nitric oxide (NO˙) by nitric oxide 
synthase or superoxide (O2˙) by NADPH oxidase (NOX). ATP is produced by glycolytic production of glucose to pyruvate and NADH. 
Pyruvate and NADH are normally oxidized to CO2 and NAD
+ by mitochondrial respiration to generate additional ATP. Under ischemic con-
ditions, oxidative metabolism cannot occur, and NAD+ is instead regenerated by the formation of lactic acid. During reperfusion, damaged 
mitochondria may produce superoxide by donating glucose-derived reducing equivalents to molecular oxygen.
Figure 2. Differing effects of hyperglycemia on ischemic core, 
penumbra, and reperfusion. Complete or near-complete ischemia 
in core regions with poor collateral circulation leads to glucose 
and oxygen depletion, accompanied by ATP depletion and mild 
acidosis. Hyperglycemia supports metabolism and exacerbates 
acidosis to only a minor degree in core regions, because only 
glucose present at the onset of ischemia is metabolized. Penum-
bral regions with residual blood flow through collateral circulation 
receive continued glucose but not oxygen delivery because of 
the molar excess of glucose in arterial blood. Glycolysis fueled 
by the continued glucose delivery can attenuate ATP depletion, 
but also generates lactic acidosis in proportion to blood glucose 
levels. During reperfusion, pH is normalized and ATP recovers 
where the tissue is still viable, but with increased glucose deliv-
ery, there is increased production of reactive oxygen species 
(ROS). ↑ indicates increased; ↓, decreased; –, no change; +/-, 
variable; and nl, normal.
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energy production, it is likely that much smaller reductions 
in blood glucose may exacerbate injury in ischemic brain. 
However, the only published study directly addressing this 
issue examined retinal rather than brain pathology.15
On the other hand, elevated blood glucose concentrations 
can exacerbate cell injury by multiple mechanisms. Acidosis 
has long been recognized as one such mechanism, but even 
acidosis has complex and competing effects on ischemic cell 
survival. Normal brain pH is ≈7.2. During ischemia, anaerobic 
metabolism of glucose to lactic acid can reduce this to ≈6.6 
under normoglycemic conditions and <6.0 under hyperglyce-
mic conditions.16 Modest levels of acidosis, to ≈pH 6.7, inhibit 
the production of superoxide by NADPH oxidase and are 
robustly neuroprotective in ischemia.17,18 More severe reduc-
tions in pH are thought to exacerbate ischemic brain injury 
by causing protein denaturation, activation of acid-sensing ion 
channels, and release of ferrous iron.19,20 It should be noted, 
however, that despite these potential injury mechanisms, there 
has been no direct demonstration that acidosis has a causal 
role in hyperglycemic exacerbation of brain injury, because 
this would require evidence that the deleterious effects of 
hyperglycemia can be negated by normalizing brain pH.
The requisite role of glucose in the production of super-
oxide and nitric oxide provides an additional mechanism of 
glucose-mediated injury that may be particularly important 
during reperfusion.21 The formation of these reactive oxygen 
species requires oxygen and, therefore, cannot occur under 
the anaerobic conditions of severe or complete ischemia. 
With reperfusion there is both an influx of oxygen and a nor-
malization of pH, which releases acid-mediated inhibition of 
NADPH oxidase.17 Superoxide production by NADPH oxi-
dase during reperfusion is increased by hyperglycemia and 
decreased by reducing cellular glucose utilization, NADPH 
oxidase activity, or brain pH.13,17,22
Hyperglycemia may also promote ischemic injury by other 
mechanisms, including enhanced glucose–sodium exchange 
and formation of abnormal protein glycosylation and advanced 
glycation products,23–25 but a definitive role for these pro-
cesses in acute ischemic injury has not yet been established. 
Hyperglycemia is also strongly associated with an intensified 
postischemic inflammatory response, but it has been difficult 
to unravel whether the increased inflammation is a cause or 
result of increased ischemic brain injury. Interestingly, it has 
also been suggested that glucose-induced cortisol elevations, 
rather than glucose per se, exacerbate ischemic brain injury 
in experimental stroke.26 Cortisol can indeed potentiate neu-
ronal death, but the magnitude of glucose-induced cortisol 
elevations has been disputed,24 and this explanation would not 
account for the effects of interventions that negate the effects 
of hyperglycemia.
Metabolic Heterogeneity in Brain Ischemia
The opposing effects of glucose on ischemic brain injury 
are further complicated by the metabolic heterogeneity of 
ischemic tissue. The classic concept of ischemic core and 
penumbra has stood the test of time, with the core defined 
as tissue with zero or near-zero blood flow in which energy 
failure occurs within minutes. The term ischemic penumbra 
was originally introduced to describe regions with reduced 
blood flow that are electrically silent but viable if blood flow 
is restored,27 but the term is now applied more generally to 
ischemic brain regions that are metabolically compromised 
but potentially salvageable.28 The flow thresholds at which 
these conditions occur are somewhat variable between brain 
regions and with duration of ischemia.
The bioenergetic state and response to hyperglycemia in 
these regions are different (Figure 2). At one extreme, a core 
region of focal ischemia may have no residual blood flow at 
all, in which case circulating blood glucose concentrations 
are of little consequence. This may occur in areas with poor 
collateral circulation, such as lacunar strokes affecting deep 
white matter regions, or in the core areas of large cortical isch-
emic territories. Interestingly, this is the one setting in which 
hyperglycemia has repeatedly been shown not to exacerbate 
experimental ischemic brain injury and may in fact have a 
beneficial effect.2,29 The beneficial effect may stem from the 
ability of glucose to fuel the high energy demand imposed by 
spreading depression near ischemic core regions.30
Where collateral circulation exists, as is more commonly the 
case, a penumbral region of reduced but nonzero blood flow is 
formed between nonischemic tissue and an ischemic tissue (or 
in the absence of a core). The molar excess of glucose over oxy-
gen in arterial blood dictates that glucose delivery will continue 
to these ischemic regions even after all extractable oxygen was 
removed, permitting ATP production by glucose metabolism to 
lactic acid. ATP consumption is slowed down in these penum-
bral regions by cessation of electric activity, but there remains 
a residual ATP demand for continued cell viability. Anaerobic 
metabolism of glucose to lactic acid produces only 1/16th as 
much ATP per molecule of glucose as normal oxidative metab-
olism, and consequently tissue viability in these regions can be 
maintained only by increasing the rate of glucose utilization to 
values higher than in nonischemic tissues.30,31
The ischemic penumbra is unstable and dynamic with 
both regional and temporal fluctuations in blood flow.28,31 
Hyperglycemia has complex effects on metabolism in the 
region. Where blood flow is only modestly reduced, lactic acid 
can be cleared, and the additional ATP production fueled by aug-
mented glucose delivery may prevent the release of excitotoxic 
glutamate and other sequelae of energy failure.28 Conversely, 
where (or when) ischemia is more severe, lactic acid accumu-
lates and pH falls in proportion to blood glucose levels.32
Effects of Hyperglycemia on Vascular Injury
Ischemic injury to the cerebral vasculature may be particu-
larly dependent on circulating glucose concentrations. In 
animal models of ischemia/reperfusion, hyperglycemic has 
frequently been associated with a striking no reflow of blood 
into the microvasculature, along with evidence of increased 
blood–brain barrier disruption.33 It is possible that these 
effects on vasculature are also a manifestation of increased 
parenchymal injury, but evidence also exists for direct effects 
of hyperglycemia on cerebrovascular tone and endothelium, 
resulting in increased edema formation, increasing hemor-
rhage, and reduced microvascular reflow. Several interre-
lated mechanisms have been identified by which glucose can 
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induce these changes, including increased endothelial protein 
kinase C activation, amplified inflammatory responses, and 
increased superoxide generation.22,34–36 Hyperglycemia also 
increases the rate of tissue plasminogen activator–induced 
hemorrhage in a model of ischemia/reperfusion, and the 
reversal of this effect by the inhibitors of NADPH oxidase 
further suggest that glucose-fueled superoxide production 
contributes to vascular injury.22
Correlations Between Experimental and 
Clinical Observations
Animal models of stroke differ in important ways from clini-
cal stroke in that the subjects are almost young, healthy, male, 
and under general anesthesia. In addition, animal models of 
 stress-induced hyperglycemia almost always use exogenous 
glucose administration, which elevates insulin secretion, 
whereas stress-induced hyperglycemia results from an increase 
in circulating catecholamines, which suppress insulin secretion. 
These factors could in principle skew the experimental stroke 
literature, but despite these limitations, there is a strong agree-
ment between experimental and clinical observations. Clinical 
studies show a robust association between elevated admission 
hyperglycemia and negative outcome measures such as infarct 
size, mortality, disability, and poor recovery. This association 
is observed in ischemic stroke with or without thrombolysis 
and in patients with intracerebral hemorrhage, and it remains 
significant in studies using logistic regression analysis to con-
trol for several confounding factors.4,8,37
Recent clinical studies using imaging end points have fur-
ther confirmed this relationship. A study using transcranial 
Doppler, MRI, and magnetic resonance spectroscopy showed 
that hyperglycemia is a strong predictor of infarct growth and 
poor outcome, even when statistically accounting for origi-
nal infarct size, size of perfusion mismatch deficit, National 
Institutes of Health Stroke Scale on admission, and time to 
vessel reperfusion.38 A subsequent study similarly showed 
that for patients with evidence of diffusion/perfusion mis-
match, admission hyperglycemia is independently associated 
with infarct size, progression of ischemic penumbra to infarct, 
and lactate peaks in the penumbra.39 Interestingly, for those 
subjects with little diffusion/perfusion mismatch (indicat-
ing a minimal penumbra), there was no relationship between 
hyperglycemia and lactate peaks or outcome measures,39 and 
in a separate study, insulin treatment tended to increase rather 
than decrease ultimate infarct size in hyperglycemic patients 
with complete arterial occlusion.40 These results are consistent 
with studies in animal stroke models showing little or no detri-
mental effect of hyperglycemia in complete ischemia.29 They 
also agree with clinical observations that hyperglycemia is not 
detrimental and may even be beneficial in lacunar strokes,41,42 
which occur most frequently in end-arterial vascular territo-
ries with poor collateral flow. Also in parallel with the results 
of animal studies, evaluations of hemorrhagic risk after throm-
bolytic therapy identify hyperglycemia to be strongly associ-
ated with both hemorrhage and poor outcomes,6,43 particularly 
in the setting of vessel recanalization.44
Nevertheless, despite well-established injury mechanisms 
and a general agreement between the experimental and clinical 
literature, there remains some evidence against a causal role 
of hyperglycemia in exacerbating ischemic injury. One recent 
study suggests that diabetes mellitus and stroke severity may 
be more important factors than admission blood glucose levels 
per se,45 and 2 studies that measured serum cortisol found that 
these levels better predicted poor stroke outcomes compared 
with blood glucose levels.46,47
Prospective Trials
A Cochrane review of 7 trials completed before June 2010 
concluded that treatment with intravenous insulin to maintain 
normoglycemia after ischemic stroke provides no benefit in 
terms of functional improvement, ultimate functional out-
come, or death.4 Two subsequent studies arrived at similar 
conclusions,40,48 but the concern remains that even the largest 
of these studies were underpowered.7 The prospective studies 
also noted a significant increase in the number of hypogly-
cemic episodes in insulin-treated patients. Although glucose 
levels rarely fell to levels normally considered dangerous, it 
is possible that even modest reductions in circulating glucose 
concentrations can have a negative impact on energy metabo-
lism in ischemic brain for reasons discussed above. An ongo-
ing multicenter clinical trial with targeted enrollment of 1400 
patients will assess the effects of aggressive glucose control 
starting <12 hours of stroke symptom onset.7
Conclusions
The experimental literature identifies fundamental complexi-
ties in the role of glucose and ischemic injury. Hyperglycemia 
can enhance glucose delivery and preserve ATP levels in isch-
emic tissue, but at the cost of deleterious lactic acidosis and 
oxidative stress. In an individual case, it is currently not pos-
sible to predict which of these factors will prevail, and the 
heterogeneous and dynamic nature of ischemic brain lesions 
makes it likely that both negative and positive effects may 
occur within a given lesion over time. The preponderance of 
evidence suggests that the deleterious effects of hyperglyce-
mia will dominate in most settings, but there is clinical and 
experimental evidence that lesions with complete ischemia 
are least likely to be exacerbated by hyperglycemia and may 
even be helped.
These opposing effects of hyperglycemia on ischemic brain 
likewise contribute to the difficulty in determining in any 
given patient whether aggressive glucose management will be 
helpful. Future advances in spectroscopic and other imaging 
modalities may provide information on collateral circulation 
and metabolic state of penumbral tissues that may help dis-
tinguish those patients who are at high risk because of ongo-
ing hyperglycemia from those in whom reductions in blood 
glucose may be particularly hazardous. Perhaps the greatest 
promise lies in interventions targeting specific deleterious 
processes induced by hyperglycemia, because these could in 
principle obviate the need for normalizing blood glucose con-
centrations in acute stroke.
In contrast to this somewhat mixed effects of hyperglyce-
mia on ischemic brain, the experimental literature indicates 
a univalently negative effect of hyperglycemia in the setting 
of reperfusion. The clinical experience likewise indicates a 
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particularly negative effect of hyperglycemia during reperfu-
sion; nevertheless, hyperglycemia is not presently identified 
as a contraindication to thrombolytic therapy (except as a 
potential stroke mimic). This issue may warrant re-examina-
tion—not only because thrombolytic therapy could have a net 
negative effect in this patient group but also because removing 
this group from treated cohorts may reveal a longer window of 
opportunity for treatment or lower hemorrhage rates in nonhy-
perglycemic patients. These issues are currently being evalu-
ated in an ongoing clinical trial.7
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